Trial record 1 of 1 for: chronic obstructive pulmonary disease | NCT01136239
Previous Study | Return to List | Next Study
The Effect of High Dose N-acetylcysteine on Airtrapping and Airway Resistance in Chronic Obstructive Pulmonary Disease (COPD) Patients
This study has been completed.
Kwong Wah Hospital
First Posted: June 3, 2010
Last Update Posted: April 9, 2015
Information provided by (Responsible Party):
Tse Hoi Nam, Kwong Wah Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||February 2012|
|Primary Completion Date:||February 2012 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Tse HN, Raiteri L, Wong KY, Ng LY, Yee KS, Tseng CZS. Benefits of high-dose N-acetylcysteine to exacerbation-prone patients with COPD. Chest. 2014 Sep;146(3):611-623. doi: 10.1378/chest.13-2784.